1. Gomes, P. J. (2014). Trends in prevalence and treatment of ocular allergy. Current opinion in allergy and clinical immunology, 14(5), 451-456.

2. Abelson MB et al. Pediatr Allergy Immunol 2004;15(6):551-7.

3. Abelson MB et al. Arch Ophthalmol 2003;121(5):626-30

4. Zaditen (Ketotifen) Product Information, 2011.

5. Information for patients, consumers and carers. Pollen allergy. ASCIA Australasian society of clinical immunology and allergy. Available at: https://www.allergy.org.au/. Accessed 11 May 2016.

6. Naphcon-A (Pheniramine maleate/Naphazoline hydrochloride) Product information,2013.

7. Visine Allergy (Pheniramine maleate/Naphazoline hydrochloride) Visine website https://www.visine.com.au/eye-drops/allergy-eyes/visine-allergy . Accessed on 21 August 2017

8. Zyrtec (Levocabastine) Product Information, 2014.

9. Livostin (Levocabastine hydrochloride) Product Information, 2010.

10.Opticrom (Sodium cromoglycate) Product Information, 2013..

11.Bielory L et al. MedGenMed 2007;9(3):35

12.Bielory L. Immunol Allergy Clin North Am 2008;28(1):189-224,vii